Sionna Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -147 | |||
EBITDA | -21,906 | -19,228 | -17,966 | |
EBIT | -22,053 | -19,387 | -18,133 | -27,984 |
Net Income | -18,068 | -16,482 | -15,848 | -25,441 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,153 | -16,374 | -11,808 | -17,686 |
Cash | 40,985 | 82,695 | 37,788 | 35,749 |
Basic Shares | 44,116 | 26,596 | 42,401 | 42,444 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -69,888 | -49,750 | -41,250 |
EBIT | -70,556 | -50,333 | -41,372 |
Net Income | -61,688 | -47,263 | -40,240 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -52,814 | -44,815 | -37,942 |
Cash | 37,788 | 38,521 | 54,837 |
Basic Shares | 42,444 | 27,797 | 17,332 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.40 |
2025-03-31 | -$0.62 |
2024-12-31 | -$3.38 |
